Allogeneic Dendritic Cell (DC) Vaccination as an “Off the Shelf” Treatment to Prevent or Delay Relapse in Elderly Acute Myeloid Leukemia Patients: Results of Phase I/IIa Safety and Feasibility Study
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-1-s1-p205
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
BMJ